TNYA
Income statement / Annual
Last year (2023), Tenaya Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Tenaya Therapeutics, Inc.'s net income was -$124.08 M.
See Tenaya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$8.69 M |
$8.71 M |
$4.03 M |
$2.48 M |
$1.99 M |
| Gross Profit |
-$8.69 M |
-$8.71 M |
-$4.03 M |
-$2.48 M |
-$1.99 M |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$98.04 M
|
$94.54 M
|
$54.39 M
|
$31.10 M
|
$23.15 M
|
| General & Administrative
Expenses |
$33.16 M
|
$31.08 M
|
$18.41 M
|
$7.81 M
|
$4.56 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$33.16 M
|
$31.08 M
|
$18.41 M
|
$7.81 M
|
$4.56 M
|
| Other Expenses |
$0.00 |
$2,000.00 |
-$23,000.00 |
$430,000.00 |
$1.03 M |
| Operating Expenses |
$131.19 M |
$125.62 M |
$72.81 M |
$38.91 M |
$27.71 M |
| Cost And Expenses |
$131.19 M |
$125.62 M |
$72.81 M |
$38.91 M |
$27.71 M |
| Interest Income |
$7.06 M |
$1.95 M |
$108,000.00 |
$87,000.00 |
$453,000.00 |
| Interest Expense |
$0.00 |
-$1,956.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$8.69 M
|
$8.71 M
|
$4.03 M
|
$2.48 M
|
$1.99 M
|
| EBITDA |
-$122.51 M
|
-$114.95 M
|
-$68.70 M
|
-$36.43 M
|
-$25.72 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$7.11 M
|
$1.96 M
|
$85,000.00
|
$517,000.00
|
$1.48 M
|
| Income Before Tax |
-$124.08 M |
-$123.67 M |
-$72.72 M |
-$38.40 M |
-$26.23 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$1,956.00 |
-$3.07 M |
-$87,000.00 |
-$453,000.00 |
| Net Income |
-$124.08 M |
-$123.66 M |
-$69.65 M |
-$38.31 M |
-$25.78 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.68 |
-2.76 |
-1.69 |
-0.93 |
-0.63 |
| EPS Diluted |
-1.68 |
-2.76 |
-1.69 |
-0.93 |
-0.63 |
| Weighted Average Shares
Out |
$73.79 M
|
$44.82 M
|
$41.29 M
|
$41.12 M
|
$41.12 M
|
| Weighted Average Shares
Out Diluted |
$73.79 M
|
$44.82 M
|
$41.29 M
|
$41.12 M
|
$41.12 M
|
| Link |
|
|
|
|
|
